Artemis Investment Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Artemis Investment Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-535,823	Closed	-$25.3M	–	266
2022 Q3	$25.3M	Sell	535,823 -579,972	-52%	-$37.5M	0.29%	96
2022 Q2	$80.1M	Sell	1,115,795 -55,480	-5%	-$4.06M	0.82%	38
2022 Q1	$94.7M	Buy	1,171,275 +11,869	+1%	+$1M	0.76%	34
2021 Q4	$119M	Buy	1,159,406 +139,178	+14%	+$13.4M	0.86%	32
2021 Q3	$89.2M	Buy	1,020,228 +131,197	+15%	+$11.9M	0.71%	38
2021 Q2	$79.6M	Buy	889,031 +174,567	+24%	+$14.7M	0.69%	41
2021 Q1	$54.2M	Buy	714,464 +330,429	+86%	+$24.9M	0.51%	53
2020 Q4	$26.2M	Buy	+384,035	New	+$23.9M	0.27%	115

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Artemis Investment Management's SYNH Position: Q4 2022 in Review

Artemis Investment Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 535,823 shares — an estimated $25.3M sold.

Artemis Investment Management first reported a position in SYNH in Q4 2020 and held it in 8 quarters. The position peaked at $119M in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Artemis Investment Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Artemis Investment Management sold 535,823 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $25.3M.
Artemis Investment Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 8 quarters.
Artemis Investment Management's Syneos Health, Inc. Class A Common Stock position peaked at $119M in Q4 2021.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Artemis Investment Management's 13F filing for Q4 2022, filed 25 Jan 2023.